Glossary

Federated GWAS

A decentralized implementation of Genome-Wide Association Studies that computes variant-disease associations across distributed biobanks by sharing only aggregated allele frequencies and summary statistics rather than raw genotypic data.

Get in touch Learn more

Data scientist building training data pipeline on laptop, data preprocessing visible, technical workspace.

DEFINITION

What is Federated GWAS?

Federated GWAS is a privacy-preserving computational architecture that executes Genome-Wide Association Studies across multiple distributed biobanks without centralizing individual-level genotypic data. Instead of pooling raw genetic sequences, each participating site locally computes summary statistics—such as allele frequencies, effect sizes, and standard errors—for each single nucleotide polymorphism (SNP) against a phenotype of interest. Only these aggregated, non-identifiable statistical outputs are transmitted to a central meta-analysis engine, which harmonizes the results using methods like inverse variance weighting to produce a single pooled estimate of genetic association.

This approach directly addresses the regulatory and ethical barriers that prevent cross-institutional genomic data sharing under frameworks like GDPR and HIPAA. By keeping sensitive genomic data behind local firewalls, federated GWAS mitigates privacy risks while dramatically increasing statistical power through larger, more diverse sample sizes. The architecture must account for population stratification and site-specific batch effects that can confound results, often requiring federated implementations of principal component analysis to correct for ancestry. The final output is typically visualized as a Manhattan plot, identifying loci that reach genome-wide significance after rigorous multiple testing correction.

DECENTRALIZED GENOMICS

Key Features of Federated GWAS

Federated GWAS distributes the computation of variant-disease associations across isolated biobanks, ensuring raw genotypic data never leaves its institutional firewall. The architecture relies on sharing only aggregated summary statistics and allele frequencies.

Privacy-Preserving Summary Statistics

The core mechanism avoids moving raw genotypes. Instead, each site computes local allele frequencies and contingency tables for case-control groups. Only these aggregated, non-identifiable statistics are transmitted to the central aggregator, ensuring compliance with GDPR and HIPAA.

Input: Local PLINK or VCF files
Output: Per-variant odds ratios and standard errors
Protection: Prevents membership inference attacks on genomic data

Inverse Variance Weighted Meta-Analysis

The global aggregator combines local effect estimates using inverse variance weighting, a statistical method that gives greater influence to sites with larger sample sizes or lower variance. This produces a single, statistically optimal pooled estimate of the genotype-phenotype association.

Computes Cochran's Q statistic for heterogeneity assessment
Generates combined p-values and confidence intervals
Handles imbalanced case-control ratios across sites

Population Stratification Correction

Federated GWAS must account for systematic ancestry differences between cohorts to avoid spurious associations. Each site applies local principal component analysis (PCA) or linear mixed models to correct for population structure before sharing summary statistics.

EIGENSTRAT or GCTA compatible
Prevents confounding from cryptic relatedness
Ensures trans-ethnic reproducibility of findings

Manhattan Plot Synthesis

The central server synthesizes a unified Manhattan plot by mapping the aggregated p-values to chromosomal coordinates. This visualization allows researchers to instantly identify genome-wide significant loci that cross the Bonferroni-corrected threshold (typically p < 5×10⁻⁸).

Interactive LocusZoom-style regional views
Highlights lead SNPs and linkage disequilibrium blocks
Facilitates downstream gene prioritization

Secure Aggregation Protocol

To prevent the central aggregator from inferring site-specific statistics, a secure multi-party computation (SMPC) or homomorphic encryption layer masks individual contributions. The server only learns the final aggregated sum, not the intermediate local results.

Uses additive secret sharing schemes
Protects against honest-but-curious aggregators
Maintains statistical fidelity with zero information leakage

Cross-Silo Quality Control

Before meta-analysis, federated QC pipelines harmonize variant calling across sites. This includes standardizing reference genomes, aligning strand orientation, and filtering on imputation quality scores (INFO > 0.8) to ensure only high-confidence variants enter the pooled analysis.

HRC or 1000 Genomes reference panels
Hardy-Weinberg equilibrium filtering
Minor allele frequency (MAF) thresholding

Enabling Efficiency, Speed & Accuracy

Intelligent Analysis, Decision & Execution

We build AI systems for teams that need search across company data, workflow automation across tools, or AI features inside products and internal software.

Talk to Us

Search across company data

Give teams answers from docs, tickets, runbooks, and product data with sources and permissions.

Useful when people spend too long searching or get different answers from different systems.

Enterprise searchRAGPermissions

Automate internal workflows

Use AI to route work, draft outputs, trigger actions, and keep approvals and logs in place.

Useful when repetitive work moves across multiple tools and teams.

AI agentsWorkflow automationGovernance

Add AI to products and internal tools

Build assistants, guided actions, or decision support into the software your team or customers already use.

Useful when AI needs to be part of the product, not a separate tool.

AI integrationDecision supportModel routing

FEDERATED GWAS

Frequently Asked Questions

Clear, technically precise answers to the most common questions about performing Genome-Wide Association Studies across distributed biobanks without centralizing raw genotypic data.

Federated GWAS is a decentralized implementation of Genome-Wide Association Studies that computes variant-disease associations across distributed biobanks by sharing only aggregated allele frequencies and summary statistics rather than raw genotypic data. The process works by distributing a common analysis protocol to each participating institution, which then executes quality control, imputation, and single-variant association tests locally behind its firewall. Each site computes contingency tables or logistic regression coefficients for every single nucleotide polymorphism (SNP) against the phenotype of interest, then transmits only these aggregated summary statistics—such as effect sizes, standard errors, and p-values—to a central meta-analysis engine. The central server applies inverse variance weighting to combine site-specific results into a single pooled effect estimate, producing a Manhattan plot that visualizes genome-wide significance. Crucially, individual-level genotypes never leave the originating institution, satisfying GDPR, HIPAA, and institutional data use agreements while enabling sample sizes that would be impossible under centralized pooling.

CONCEPTS

Related Terms

Core statistical and methodological concepts essential for understanding and executing a Federated GWAS.

Manhattan Plot

A scatter plot used to visualize the statistical significance of association between genetic variants and a trait. The negative logarithm of the p-value is plotted against chromosomal position, creating a skyline-like figure where highly significant associations stand out as tall peaks. In a federated context, this plot is generated from meta-analyzed summary statistics without ever pooling raw genotype data.

5×10⁻⁸

Genome-wide significance threshold

Population Stratification

A confounding factor caused by systematic differences in allele frequencies between subpopulations due to ancestry. If cases and controls have different ancestral backgrounds, spurious associations can arise. Federated GWAS must apply corrections like genomic control or principal component analysis locally at each biobank before meta-analysis to prevent false positives.

Multiple Testing Correction

A statistical adjustment applied to p-values when performing millions of simultaneous hypothesis tests. Without correction, the probability of false positives explodes. Common methods include:

Bonferroni correction: Divides the significance threshold by the number of tests
Benjamini-Hochberg: Controls the false discovery rate In GWAS, the standard genome-wide significance threshold is p < 5×10⁻⁸.

Heterogeneity Assessment

The statistical evaluation of variability in effect estimates across different study sites. Quantified using the I² statistic or Cochran's Q test, this determines whether pooling results in a meta-analysis is appropriate. High heterogeneity in a federated GWAS may indicate genuine biological differences between populations or systematic biases in phenotype definitions across sites.

Forest Plot

A graphical display showing the point estimates and confidence intervals of individual study effects alongside the pooled summary effect. In a federated GWAS, each biobank contributes one row, allowing visual assessment of consistency. A diamond at the bottom represents the meta-analyzed odds ratio, with its width indicating the confidence interval.

Inverse Variance Weighting

A statistical aggregation method that assigns greater weight to studies with smaller variance—typically those with larger sample sizes—to compute an optimal pooled effect estimate. In federated GWAS, this is the standard approach for combining beta coefficients and standard errors from each site's association tests into a single meta-analyzed result.

About the author

Prasad Kumkar

CEO & MD, Inference Systems

Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.

His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.

Limited slotsGet a Free AI Consultation

How We Work

Custom AI workflows for your Business

One-fit-all AI don't work for modern businesses. At Inferensys, we aim to understand your business & custom requirements; which we use to define most efficient agentic workflows, the data, and the tools for your business.